Franklin Resources Portfolio holdings
Franklin Resources, Inc., commonly known as Franklin Templeton, was founded in 1947 by Rupert H. Johnson, Sr., and is headquartered in San Mateo, California, operating as a global investment management firm managing hundreds of billions in assets. The company offers a wide range of investment products, including mutual funds, ETFs, fixed-income portfolios, and alternative investments, serving individual investors, financial advisors, and institutions across over 150 countries. Known for its acquisition-driven growth—such as the 1992 purchase of Templeton Investments and the 2020 addition of Legg Mason—Franklin Templeton combines diverse strategies under a single brand, emphasizing both active management and income-focused solutions like its flagship Franklin Income Fund. With a reputation for adaptability and a client-centric approach, it remains a major player in the global asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Franklin US Large Cap Multifactor Index ETF
FLQL
|
+$514M |
| 2 |
Target
TGT
|
+$487M |
| 3 |
Wells Fargo
WFC
|
+$384M |
| 4 |
Apple
AAPL
|
+$257M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$247M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$597M |
| 2 |
Restaurant Brands International
QSR
|
+$349M |
| 3 |
Microsoft
MSFT
|
+$318M |
| 4 |
JPMorgan Chase
JPM
|
+$310M |
| 5 |
Analog Devices
ADI
|
+$268M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.33% |
| 2 | Technology | 15.62% |
| 3 | Financials | 14.4% |
| 4 | Industrials | 9.04% |
| 5 | Communication Services | 7.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARRY
201
DELISTED
Array Biopharma Inc
ARRY
| $256M | 0.14% |
10,502,369
+1,086,167
| +12% | +$22.6M |
|
202
Biogen
BIIB
$29.9B
| $255M | 0.14% |
1,076,953
-115,763
| -10% | -$36.5M |
|
203
Evergy
EVRG
$20.1B
| $252M | 0.13% |
4,335,584
+18,961
| +0.4% | +$1.08M |
|
|
TIF
204
DELISTED
Tiffany & Co.
TIF
| $249M | 0.13% |
2,355,092
+70,605
| +3% | +$6.48M |
|
205
Pentair
PNR
$10.2B
| $248M | 0.13% |
5,569,298
-461,825
| -8% | -$19.2M |
|
206
American Water Works
AWK
$26.3B
| $245M | 0.13% |
2,349,574
-13,762
| -0.6% | -$1.35M |
|
|
ZEN
207
DELISTED
ZENDESK INC
ZEN
| $245M | 0.13% |
2,881,883
-223,357
| -7% | -$16.4M |
|
208
Waters Corp
WAT
$36.9B
| $243M | 0.13% |
966,782
-14,377
| -1% | -$3.28M |
|
209
Veeva Systems
VEEV
$30.3B
| $238M | 0.13% |
1,877,852
+252,936
| +16% | +$28.5M |
|
210
Banco Bradesco
BBD
$38.1B
| $237M | 0.13% |
34,691,813
| – | – |
|
211
Regeneron Pharmaceuticals
REGN
$69.1B
| $234M | 0.13% |
569,660
-10,047
| -2% | -$4.14M |
|
212
Telus
TU
$16B
| $229M | 0.12% |
12,359,016
+1,391,724
| +13% | +$24.6M |
|
213
Cardinal Health
CAH
$53.3B
| $226M | 0.12% |
4,690,638
+1,526
| +0% | +$76.5K |
|
214
Electronic Arts
EA
$52.4B
| $225M | 0.12% |
2,218,068
-212,527
| -9% | -$20.1M |
|
215
First Horizon
FHN
$12.1B
| $225M | 0.12% |
16,107,427
| – | – |
|
|
VSM
216
DELISTED
Versum Materials, Inc.
VSM
| $224M | 0.12% |
4,444,427
-1,774,139
| -29% | -$70.6M |
|
|
ALXN
217
DELISTED
Alexion Pharmaceuticals
ALXN
| $220M | 0.12% |
1,624,961
-400,614
| -20% | -$49.8M |
|
218
Vertex Pharmaceuticals
VRTX
$122B
| $213M | 0.11% |
1,160,123
-53,371
| -4% | -$9.86M |
|
219
Vornado Realty Trust
VNO
$7.51B
| $213M | 0.11% |
3,160,610
+71,453
| +2% | +$4.79M |
|
220
iShares Core MSCI Emerging Markets ETF
IEMG
$149B
| $213M | 0.11% |
4,109,478
+1,279,874
| +45% | +$64.8M |
|
221
Newell Brands
NWL
$2.16B
| $212M | 0.11% |
13,847,477
+1,763,779
| +15% | +$32.4M |
|
222
Equinix
EQIX
$107B
| $212M | 0.11% |
468,182
-2,255
| -0.5% | -$918K |
|
223
Heron Therapeutics
HRTX
$85.4M
| $210M | 0.11% |
8,578,877
+157,586
| +2% | +$4.13M |
|
224
TSMC
TSM
$2.09T
| $205M | 0.11% |
5,011,971
-327,853
| -6% | -$12.5M |
|
225
Entergy
ETR
$53.9B
| $205M | 0.11% |
4,280,864
-1,995,138
| -32% | -$90.2M |
|
Similar funds
Franklin Resources's Q1 2019 Portfolio in Review
As of Q1 2019, Franklin Resources held 1,583 positions worth $187B, up 13% from $166B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Franklin Resources's Q1 2019 filing shows 113 new, 618 increased, 562 reduced and 100 closed positions. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 1,189,251 shares worth $200M. The largest sale was Eli Lilly, an estimated $597M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Technology and Financials.
- Franklin Resources's largest Q1 2019 buy was GW Pharmaceuticals Plc American Depositary Shares: 1,189,251 shares worth $200M.
- Franklin Resources added most to Franklin US Large Cap Multifactor Index ETF in Q1 2019, an estimated $514M increase.
- Franklin Resources's biggest Q1 2019 reduction was Eli Lilly, cutting an estimated $597M.
- Franklin Resources fully exited FCB Financial Holdings, Inc. in Q1 2019, selling an estimated $79.2M.
- Franklin Resources's ten largest holdings make up 12% of its $187B portfolio in Q1 2019.
- Franklin Resources opened 113 new positions and closed 100 in Q1 2019.
- Franklin Resources's portfolio value rose 13% quarter-over-quarter to $187B.
Based on Franklin Resources's 13F filing for Q1 2019, filed 14 May 2019.